Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Optical Biopsy in Gynecological Surgery

NCT: NCT04154683 · COMPLETED

NCT IDNCT04154683
StatusCOMPLETED
Start Date2020-06-29
Completion2026-08-28
SponsorHospices Civils de Lyon (OTHER)
First posted
Last updated

Brief Summary

Optical biopsy is a new technology that generates a real-time, cell-based, high-resolution view and analysis of tissues. Observation is instantaneous and non-invasive. This allows reliable and fast diagnosis which facilitates decision making as well as patient management. The investigator have already conducted a feasibility study on the use of this new technology to evaluate ovarian and tubal pre-cancerous lesions in laparoscopy. In this new study, he wants to continue investigations, expand its use to other gynecological pathologies, and demonstrate the benefit of such a non-invasive technology in gynecology on the one hand in the diagnosis of lesions but also to appreciate the margins as accurately as possible surgical excision of tumors and / or endometriosis lesions. The investigator have set up a prospective monocentric descriptive study. The hypothesis is that optical biopsy by Cellvizio® allows to observe in real time microscopically tissues and to characterize them in the field of gynecological surgery

Frequently Asked Questions

What is Optical Biopsy in Gynecological Surgery?

Optical Biopsy in Gynecological Surgery is a clinical trial registered under NCT04154683. Current status: COMPLETED.

What is the status of NCT04154683?

The current status of NCT04154683 (Optical Biopsy in Gynecological Surgery) is: COMPLETED.

When did Optical Biopsy in Gynecological Surgery start?

Optical Biopsy in Gynecological Surgery started on 2020-06-29.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.